Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132212) titled 'Exploring the early warning signals of glioblastoma over time' on Sept. 10.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Renji Hospital, Shanghai Jiaotong University School of Medicine
Condition:
Glioma
Intervention:
Glioma group:None
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-10-01
Target Sample Size: Glioma group:150;None cancer group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=342439
Published by HT Digital Content Services with permission from Health Daily Digest....